Navigation Links
AMDL, Inc. Signs First Customer Agreement With Precision Diagnostic Laboratory for DR-70 (FDP) Cancer Test
Date:4/30/2009

PDL first diagnostic laboratory to offer DR-70 diagnostic test to doctors and patients in US; AMDL executes on worldwide product commercialization strategy

TUSTIN, Calif., April 30 /PRNewswire-FirstCall/ -- AMDL, Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with operations in China, announced today it has signed Precision Diagnostic Laboratory (PDL) Inc. as its first customer to offer the AMDL DR-70 (FDP) in vitro cancer test to patients and doctors in the US.

PDL Inc. is a full-service, CAP (College of American Pathologists) and CLIA-certified clinical laboratory that works directly with physicians, their staffs, and end patients to deliver reliable, timely, high-quality and accurate diagnostic testing. With this agreement, PDL is the first diagnostic laboratory in the US to offer the AMDL DR-70 (FDP) in vitro cancer test to doctors and their patients. To drive product awareness and education, AMDL and PDL will jointly train physicians and market the product to physicians and their patients in the US.

AMDL's agreement with PDL marks a critical milestone in an international commercialization strategy AMDL is executing for the test. This year, the Company expects to expand product distribution and sales into up to ten worldwide markets which could lead to up to $5 million in DR-70 sales for FY2009.

Mr. Doug MacLellan, Executive Chairman and CEO of AMDL stated, "This is a significant and highly-anticipated milestone in the commercialization and distribution for our DR-70 cancer test. We have extremely aggressive business and financial targets for this product and are very pleased to initiate sales with a highly-respected diagnostic lab like PDL for this potentially life-saving cancer test."

Mr. Minh Nguyen, CEO of PDL Inc. also commented, "Our agreement for AMDL's DR-70 blood test will expand market opportunities for PDL, especially within
'/>"/>

SOURCE AMDL, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor
2. Rudd Report Highlights AMDL, Inc.s Latest Business Achievements; Supports 2008 Financial Guidance
3. The Wall Street Transcript Interviews AMDL, Inc. CEO & President Gary Dreher for Fall Healthcare Issue
4. AMDL, Inc. Closes Private Placement of Convertible Notes
5. AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008
6. AMDL, Inc. Announces Strategic Realignment
7. AMDL, Inc. Named to Deloitte LLC Technology Fast 50
8. AMDL, Inc.s President & CEO Mr. Gary Dreher Retires
9. AMDL, Inc. Names Douglas MacLellan as Executive Chairman & CEO
10. AMDL, Inc. Promotes CFO Akio Ariura to Chief Operating Officer and Expands Management Team
11. AMDL, Inc. New President & CEO Douglas MacLellan to Present at Rodman & Renshaw Annual Global Investment Conference November 12, 2008
Post Your Comments:
*Name:
*Comment:
*Email: